Paracetamol

Paracetamol, also known as acetaminophen, is a widely used over-the-counter medication primarily employed for pain relief and reducing fever. It is one of the most commonly used drugs globally, available in various formulations such as tablets, capsules, and liquid suspensions. Despite its widespread use, concerns about its safety and appropriate usage have led to increased scrutiny and regulatory changes in certain regions.

Pharmacology and Mechanism of Action

Paracetamol is classified as an analgesic and antipyretic. Unlike nonsteroidal anti-inflammatory drugs (NSAIDs), it has minimal anti-inflammatory effects. Its exact mechanism of action remains incompletely understood, but it is believed to work by inhibiting cyclooxygenase (COX) enzymes in the central nervous system, reducing the production of prostaglandins, which are involved in pain and fever signaling. This selective action contributes to its generally favorable safety profile compared to NSAIDs, although it is not without risks.

Uses and Indications

Paracetamol is commonly used to treat mild to moderate pain, including headaches, muscle aches, and pain associated with colds or flu. It is also a first-line treatment for fever in both adults and children. Due to its low risk of gastrointestinal side effects, it is often preferred over NSAIDs in patients with peptic ulcers or those requiring long-term pain management. However, it is not recommended for conditions requiring anti-inflammatory effects, such as rheumatoid arthritis.

Safety and Side Effects

While generally well-tolerated at recommended doses, Paracetamol can cause severe liver damage if taken in excessive amounts. The risk of overdose is particularly high in individuals who consume alcohol or have pre-existing liver conditions. Symptoms of overdose may include nausea, vomiting, abdominal pain, and jaundice. In severe cases, it can lead to liver failure and death.

Regulatory and Public Health Considerations

Recent public health concerns have prompted regulatory changes in some countries. For example, a 2024 report by ABC News highlighted restrictions on Paracetamol sales in certain regions, citing an increase in overdoses among women and young girls. These measures aim to reduce the availability of high-dose formulations and promote safer usage practices.

References

- ABC News: https://www.abc.net.au/news/2024-12-14/Paracetamol-restrictions-prompted-by-overdoses-women-young-girls/104645168

This page contains information generated by Ollama. The information was reviewed, and may have been altered, by a human editor before being added to the Featured category. As of July 2026 information generated by AI is not subject to copyright and is thus in the public domain. This page is pending human review.